Literature DB >> 24322896

Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus.

Emmanuel C Gorospe1, Kenneth K Wang1.   

Abstract

Advances are being made in understanding the pathogenesis, treatment outcomes and surveillance of Barrett oesophagus. Central obesity and age at onset of gastro-oesophageal reflux are being recognized as risk factors that have implications for screening. The persistent finding of nondysplastic Barrett oesophagus during surveillance is associated with low risk of malignant progression, whereas dysplastic Barrett oesophagus requires continued surveillance.

Entities:  

Mesh：

Year:  2013        PMID： 24322896      PMCID： PMC4479384          DOI： 10.1038/nrgastro.2013.237

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

1.  Esophageal adenocarcinoma incidence: are we reaching the peak?

Authors:  Heiko Pohl; Brenda Sirovich; H Gilbert Welch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa.

Authors:  Elaine V Robertson; Mohammad H Derakhshan; Angela A Wirz; Yeong Yeh Lee; John Paul Seenan; Stuart A Ballantyne; Scott L Hanvey; Andrew W Kelman; James J Going; Kenneth E L McColl
Journal:  Gastroenterology       Date:  2013-06-22       Impact factor: 22.682

3.  Optimization and expansion of predictive models for Barrett's esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial?

Authors:  Michael B Cook
Journal:  Am J Gastroenterol       Date:  2013-06       Impact factor: 10.864

4.  Garlic, silver bullets, and surveillance upper endoscopy for Barrett's esophagus.

Authors:  Nicholas J Shaheen; Chin Hur
Journal:  Gastroenterology       Date:  2013-06-24       Impact factor: 22.682

5.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

6.  Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.

Authors:  Milli Gupta; Prasad G Iyer; Lori Lutzke; Emmanuel C Gorospe; Julian A Abrams; Gary W Falk; Gregory G Ginsberg; Anil K Rustgi; Charles J Lightdale; Timothy C Wang; David I Fudman; John M Poneros; Kenneth K Wang
Journal:  Gastroenterology       Date:  2013-03-15       Impact factor: 22.682

7.  Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas.

Authors:  Douglas A Corley; Kunal Mehtani; Charles Quesenberry; Wei Zhao; Jolanda de Boer; Noel S Weiss
Journal:  Gastroenterology       Date:  2013-05-11       Impact factor: 22.682

8.  Age at onset of GERD symptoms predicts risk of Barrett's esophagus.

Authors:  Aaron P Thrift; Jennifer R Kramer; Zeeshan Qureshi; Peter A Richardson; Hashem B El-Serag
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

9.  The rapid rise in gastroesophageal junction tumors: is inflammation of the gastric cardia the underwater iceberg?

Authors:  Michael Quante; Julian A Abrams; Timothy C Wang
Journal:  Gastroenterology       Date:  2013-08-23       Impact factor: 22.682

10.  Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.

Authors:  Srinivas Gaddam; Mandeep Singh; Gokulakrishnan Balasubramanian; Prashanthi Thota; Neil Gupta; Sachin Wani; April D Higbee; Sharad C Mathur; John D Horwhat; Amit Rastogi; Patrick E Young; Brooks D Cash; Ajay Bansal; John J Vargo; Gary W Falk; David A Lieberman; Richard E Sampliner; Prateek Sharma
Journal:  Gastroenterology       Date:  2013-05-25       Impact factor: 33.883
  10 in total
  2 in total

1.  Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location.

Authors:  Cary C Cotton; W Asher Wolf; Sarina Pasricha; Nan Li; Ryan D Madanick; Melissa B Spacek; Kathleen Ferrell; Evan S Dellon; Nicholas J Shaheen
Journal:  Gastrointest Endosc       Date:  2015-03-24       Impact factor: 9.427

Review 2.  Screening for esophageal adenocarcinoma and precancerous conditions (dysplasia and Barrett's esophagus) in patients with chronic gastroesophageal reflux disease with or without other risk factors: two systematic reviews and one overview of reviews to inform a guideline of the Canadian Task Force on Preventive Health Care (CTFPHC).

Authors:  Candyce Hamel; Nadera Ahmadzai; Andrew Beck; Micere Thuku; Becky Skidmore; Kusala Pussegoda; Lise Bjerre; Avijit Chatterjee; Kristopher Dennis; Lorenzo Ferri; Donna E Maziak; Beverley J Shea; Brian Hutton; Julian Little; David Moher; Adrienne Stevens
Journal:  Syst Rev       Date:  2020-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.